A look at the following clinical trial: Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients.
A look at the following clinical trial: Therapy of the Overactive Bladder Syndrome (TOBS).
A look at the following clinical trial: Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH).
A look at the following clinical trial: Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome.
Please login or register first to view this content.
